Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32
Goldman Sachs analyst Matt Dellatorre initiates coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and announces Price Target of $32.
Share
Why It Matters
A big investment bank thinks Elanco is a good company to own. When smart investors start watching a company closely, it often means they see something worth your attention.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.